technetium tc 99m hydroxymethylene diphosphonate has been researched along with Bone Marrow Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Isozaki, E; Kanazawa, K | 1 |
| Brown, RS; Dogan, A; Ell, PJ; Harland, SJ; Masters, JR; Payne, HA | 1 |
| Fukuchi, K; Hayashida, K; Ishida, Y; Yamaguchi, M | 1 |
| Nagai, M; Nishiyama, Y; Ohkawa, M; Satoh, K; Yamamoto, Y | 1 |
| Birchall, JD; O'Connor, RA | 1 |
| Kwolek, DS; Lahr, B; Shih, WJ | 1 |
| Aburano, T; Seo, Y; Shuke, N; Usui, K; Yamamoto, W | 1 |
| Hasegawa, Y; Hashizume, T; Katuda, T; Noguti, A; Wakasugi, S | 1 |
2 trial(s) available for technetium tc 99m hydroxymethylene diphosphonate and Bone Marrow Neoplasms
| Article | Year |
|---|---|
The comparative values of bone marrow aspirate and trephine for obtaining bone scan-targeted metastases from hormone-refractory prostate cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Biopsy, Needle; Bone Marrow Examination; Bone Marrow Neoplasms; Drug Resistance, Neoplasm; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Prostatic Neoplasms; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tomography, Emission-Computed | 2002 |
Comparative whole-body 201Tl and bone scintigraphies for the detection of bone marrow involvement in multiple myeloma.
Topics: Aged; Antineoplastic Agents; Bone and Bones; Bone Marrow; Bone Marrow Neoplasms; Female; Humans; Male; Middle Aged; Multiple Myeloma; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Medronate; Thallium; Tomography, Emission-Computed; Treatment Outcome; Whole-Body Counting | 2003 |
6 other study(ies) available for technetium tc 99m hydroxymethylene diphosphonate and Bone Marrow Neoplasms
| Article | Year |
|---|---|
"Super bone scan" in a case of diffuse bone marrow metastasis of gastric adenocarcinoma.
Topics: Adenocarcinoma; Bone Marrow Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Stomach Neoplasms; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2009 |
Discrepancy between Tc-99m HMDP bone scan and F-18 FDG positron emission tomographic images in a patient with small cell lung cancer.
Topics: Bone Marrow Neoplasms; Carcinoma, Small Cell; Fluorodeoxyglucose F18; Humans; Ilium; Lung Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tomography, Emission-Computed | 2003 |
Prostatic metastases versus polycythemia on bone imaging.
Topics: Adenocarcinoma; Bone and Bones; Bone Marrow Neoplasms; Diagnosis, Differential; Humans; Male; Middle Aged; Polycythemia Vera; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Splenomegaly; Technetium Tc 99m Medronate | 2004 |
Testicular lymphoma with bone/bone marrow metastases illustrated by scrotal sonography, spinal MRI, and total body Tc-99m HMDP and Tc-99m MIBI images.
Topics: Aged; Bone Marrow Neoplasms; Bone Neoplasms; Humans; Lymphoma, B-Cell; Magnetic Resonance Imaging; Male; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi; Testicular Neoplasms; Ultrasonography | 1999 |
Sub-super bone scan caused by bone marrow involvement of prostate cancer.
Topics: Adenocarcinoma; Bone Marrow Neoplasms; Bone Neoplasms; Humans; Indium; Indium Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate | 1999 |
Potential of (99m)Tc-MIBI for detecting bone marrow metastases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Marrow Neoplasms; Bone Neoplasms; Female; Humans; Male; Middle Aged; Radionuclide Imaging; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi | 2002 |